Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

5.09
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.17
Today|||52-Week Range
6.55
+99.61%
Year-to-Date

Today’s Trading

Previous close5.09
Today’s open4.78
Day’s range4.75 - 5.22
Volume603,094
Average volume (3 months)2,348,841
Market cap$216.7M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)-19.23%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book1.57

Competitors

 Today’s
change
Today’s
% change
CASICASI Pharmaceuticals...0.000.00%
ATXIAvenue Therapeutics ...0.000.00%
XENEXenon Pharmaceutical...0.000.00%
APDNApplied DNA Sciences...0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 26, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts